research funding database


This opportunity is currently closed.

Sign up for Content alerts to stay informed when this or related funding opportunities are posted.

Drug Discovery Initiative (DDI) (neurofibromatosis)

Share this post

ERC webinar 2024
ERC webinar 2024

The Drug Discovery Initiative (DDI) from the Children’s Tumor Foundation supports neurofibromatosis drug discovery by funding researchers proposing to investigate novel or repurposed therapies for NF or to develop tools that support such research. Specifically, the DDI program aims to: 

  1. support early stage testing of therapeutic compounds for the treatment of NF
  2. support generation of new in vitro or in vivo model systems for NF

Applicants may be of any nationality and based anywhere in the world. Applicants must hold an MD or PhD; applications are also open to industry researchers. The Award provides one year of funding (inclusive of 10% indirect costs):

  • Up to $40,000 for in vitro
  • Up to $85,000 for in vivo

Applications open on January 8, 2024 and close on February 5, 2024.

The grant has closed Sign-up for our content alerts to be updated when it re-opens.

Adverts. Premium members do not see Google Ads.

Please Login / Subscribe to our premium membership to see the content. Sign up to Free trial to see detailed funding information.

non member

Sign-up for the
monthly funding newsletter

unsubscribe at any time